VC-backed Cabaletta Bio begins trading on NASDAQ
Cabaletta Bio, a biotech company, has debuted its IPO after pricing its 6.8 million shares at $11 per share. The stock began trading October 25, 2019 on the NASDAQ under the ticker symbol "CABA." Morgan Stanley, Cowen and Evercore ISI are the lead underwriters. Cabaletta Bio's pre-IPO backers include 5 AM Ventures and Adage Capital Partners.
25 October 2019•3 mins read
